FDA sees guidance on GMPs for IND products by year's end, focusing on risk, examples of what applies in certain phases.(Clinical supplies): An article from: Validation Times

Category: Book

no image

New starting at $5.95

Buy it

Product Description

This digital document is an article from Validation Times, published by Thomson Gale on April 1, 2005. The length of the article is 769 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: FDA sees guidance on GMPs for IND products by year's end, focusing on risk, examples of what applies in certain phases.(Clinical supplies)
Author: Ken Reid
Publication: Validation Times (Newsletter)
Date: April 1, 2005
Publisher: Thomson Gale
Volume: 7 Issue: 4 Page: 1

Distributed by Thomson Gale


Product Details

Publisher Thomson Gale
Number Of Pages 3
Format
  • Digital
  • HTML
Author Ken Reid
Label Thomson Gale
Studio Thomson Gale
Title FDA sees guidance on GMPs for IND products by year's end, focusing on risk, examples of what applies in certain phases.(Clinical supplies): An article from: Validation Times
Release Date 2006-01-10
Publication Date 2005-04-01
Manufacturer Thomson Gale